Gkherjer's profile picture.

Geir kåre Nyland

@Gkherjer

Pinned

We can shoot fucking rockets to the moon, and planing to invade mars. We build robots smarter then us, and stupid flying cars! We can save a human with transplant a heart of a pig, we can even make artificial neurons on silicon chip, isn’t that sick?! But what we CAN’T do, is to-


Still waiting for a Spinal Cord Injury cure☠️ Just a note for myself for the future</3 Nervgen? Elon Musk?

Gkherjer's tweet image. Still waiting for a Spinal Cord Injury cure☠️ Just a note for myself for the future&amp;lt;/3
Nervgen? Elon Musk?

Geir kåre Nyland reposted

Neuralink is accepting applications for the second participant. This is our Telepathy cybernetic brain implant that allows you to control your phone and computer just by thinking. No one better than Noland (@ModdedQuad) himself to tell you about the first!

Redefining the boundaries of human capability requires pioneers. If you have quadriplegia and want to explore new ways of controlling your computer, we invite you to participate in our clinical trial.



Geir kåre Nyland reposted

The first human received an implant from @Neuralink yesterday and is recovering well. Initial results show promising neuron spike detection.


Geir kåre Nyland reposted

Geir kåre Nyland reposted

We can shoot fucking rockets to the moon, and planing to invade mars. We build robots smarter then us, and stupid flying cars! We can save a human with transplant a heart of a pig, we can even make artificial neurons on silicon chip, isn’t that sick?! But what we CAN’T do, is to-


Geir kåre Nyland reposted

NervGen Pharma announces completion of dosing of all subjects in Phase 1 clinical trial of proprietary drug candidate NVG-291. Click link below to read full press release! nervgen.com/nervgen-pharma… #clinicaltrial #research #drugdevelopment #biotech #spinalcordinjury #nervoussystem

NervgenP's tweet image. NervGen Pharma announces completion of dosing of all subjects in Phase 1 clinical trial of proprietary drug candidate NVG-291. Click link below to read full press release! nervgen.com/nervgen-pharma… #clinicaltrial #research #drugdevelopment #biotech #spinalcordinjury #nervoussystem

Geir kåre Nyland reposted

3 days until the Neuralink update show and tell event! 🧠🤖🎉🥳


Geir kåre Nyland reposted

Dosing completed in 3rd Multiple Ascending Dose (MAD) cohort in Phase 1 Clinical Trial Of NVG-291 & Q3 '22 results in news release issued by @NervGenP today: bit.ly/3AdgCMH #clinicaltrial #Biotechnology

NervgenP's tweet image. Dosing completed in 3rd Multiple Ascending Dose (MAD) cohort in Phase 1 Clinical Trial Of NVG-291 &amp;amp; Q3 &apos;22 results in news release issued by @NervGenP today:  bit.ly/3AdgCMH
#clinicaltrial #Biotechnology

United States Trends

Loading...

Something went wrong.


Something went wrong.